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Pregestational obesity – risk factor for preeclampsia 
 
Pregestacijska debljina – čimbenik rizika za preeklampsiju 
 




Aim: The aim of the study was to determine pregestational and gestational obesity as risk factors for the 
occurrence of preeclampsia using body mass index (BMI), as the first research in the East Croatian region. 
Material and methods: This clinical study included 55 pregnant women with preeclampsia and a control 
group of 50 pregnant women without preeclampsia with measurement pregestational and gestational weight 
and body mass index. 
Results: The mean body weight of preeclampsia women was 88.195 kg; by median, the mean body weight 
of control women was 77.030 kg. In women with preeclampsia, the mean gestational weight gain was 15.709 
kg; in the control group, the mean gestational weight gain was 14.760 kg, whereas testing yielded no 
statistically significant differences in the mean weight gain between the preeclampsia women with the control 
group. The mean BMI in the group of women with preeclampsia was 32.235 kg/m2; in the control group, the 
mean BMI was 27.766 kg/m2. T-test yielded a statistically significant difference in the mean BMI between 
the preeclampsia group and control group of women with a normal course of pregnancy. 
Conclusion: In our study, we found that women with preeclampsia had significantly higher BMI values at 
conception as compared to the group of pregnant women with a normal course of pregnancy, suggesting the 
increased pregestational BMI to be a risk factor for developing preeclampsia in pregnancy. 




Cilj istraživanja je proučiti pregestacijsku i gestacijsku debljinu kao čimbenika rizika nastanka 
preeklampsije koristeći indeks tjelesne mase (ITM). Klinička studija uključila je 55 trudnica s preeklampsijom 
i 50 trudnica bez preeklampsije s mjerenjem pregestacijskog i gestacijskog ITM. Srednja vrijednost tjelesne 
težine u preeklamptičnih trudnica iznosila je 88,195 kg, a u kontrolnoj skupini 77,030 kg. Kod žena s 
preeklampsijom, srednja vrijednost gestacijske debljine je bila 15,709 kg, dok je u kontrolnoj skupini bila 
14,760 kg, gdje testirana vrijednost nije pokazala statističku značajnost između žena s preeklampsijom u 
odnosu na kontrolnu skupinu. Srednja vrijednost ITM u preeklamptičnih trudnica iznosi 32,235 kg/m2, a u 
kontrolnoj skupini ITM je iznosila 27,766 kg/m2, što je statistički značajno.  
U ovom istraživanju, dokazan je značajno viši prekoncepcijski ITM u preeklamptičnih trudnica, nego u 
skupini zdravih trudnica, što sugerira povišeni pregestacijski ITM čimbenikom rizika nastanka preeklamspije.  
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Preeclampsia, characterized by hypertension and 
proteinuria during pregnancy, currently is the leading 
cause of maternal mortality (15% – 20% in 
industrialized countries), acute and chronic morbidity, 
and overall perinatal mortality and morbidity. 
Definitive phenotype of the maternal multiorgan 
preeclampsia syndrome is known to be modulated by 
the maternal preexistent cardiovascular and metabolic 
state. Currently, identification of women at risk of 
developing preeclampsia is a major problem, as it is 
still based on epidemiological and clinical factors. 
Preeclampsia is more frequently found in nulliparae, 
multiple pregnancies, pregnant women with chronic 
hypertension and/or renal disease, pregnant women 
with a history of preeclampsia in previous pregnancies, 
pregnant women of extreme age groups (< 20 and           
> 40), adipose pregnant women, pregnant women            
with gestational diabetes, pregnant women with 
pregestational diabetes mellitus, those with thrombo-
philia, gestational trophoblastic disease, women 
undergoing methods of assisted reproduction, women 
suffering from autoimmune diseases, and low birth 
weight women.1-4 Obesity is a major risk factor for 
metabolic and cardiovascular comorbidity and a risk 
factor for perinatal complications and infertility, 
including preeclampsia.5,6 The aim of the study was to 
determine pregestational and gestational obesity as risk 
factors for the occurrence of preeclampsia using body 
mass index (BMI), as the first research in the East 
Croatian region. 
 
Material and methods 
 
This clinical study included 55 pregnant women 
with preeclampsia and a control group of 50 pregnant 
women without this complication with measurement 
pregestational and gestational weight and body mass 
index. The study was approved by the Ethics 
Committee of Osijek University Hospital Center, a 
tertiary healthcare facility in Eastern Croatia, a 
predominantly rural area traditionally using non-
Mediterranean and rather unhealthy dietary habits with 
all forms of pork as the main food, which is associated 
with a high cardiovascular and cerebrovascular 
morbidity as a major public health problem. Study 
group women were diagnosed with preeclampsia 
(blood pressure measurements on at least two 
occasions at minimum 4-h interval ≥ 140/90 mm Hg, 
and with positive proteinuria after 20th week of 
gestation, > 3 g/L during 24 hours). Control group 
women were gestational age-matched to study group 
women (> 20th week of gestation) and had a normal 
course of pregnancy. Research data relate only to 
pregnancy weight and weight gained during 
pregnancy. Women with mental retardation and 
minors were not included in the study. Prior to entering 
the study, all women were explained the purpose, 
protocol and objectives of the study. The selected 
descriptive statistics parameters were determined for 
the variables denoting particular characteristics of 
study subjects and the Shapiro-Wilks test was used 
because of the relatively small number of study 
subjects, whereas t-test and Levene test were employed 
in cases where the hypothesis of normal distribution 
was confirmed. 
Besides these, χ2-test was used on testing the 
hypothesis, while differences were considered 
statistically significant at the level of p < 0.05. Data 
were prepared by using the Microsoft Excel table 
calculator, while the SPSS (Statistical Package for the 
Social Science) and Statistics software was used on 




The mean body weight of preeclampsia women was 
88.195 kg; by median, body weight was ≤ 86 kg in one 
half and ≥ 86 kg in the other half of these women. The 
mean body weight of control women was 77.030 kg; 
by median, body weight was ≤ 77 kg in one half and ≥ 
77 kg in the other half of control women. The results 
of the Shapiro-Wilks test showed normal distribution 
of the variables analyzed. The Levene test showed 
different variances of the distributions analyzed (F = 
7.174, p = 0.009), whereas the test yielded statistically 
significant differences in the mean body weight 
between the groups of preeclampsia women and 
control women with a normal course of pregnancy           
(t = 4.097, p = 0.000) (Table 1). In women with 
preeclampsia, the mean gestational weight gain was 
15.709 kg; by median, gestational weight gain was ≤ 
15 kg in one half and ≥ 15 kg in the other half of these 
women. The minimal and maximal gestational weight 
gain was 5 and 32 kg, respectively, yielding a variation 
range of 27 kg. In the control group, the mean 
gestational weight gain was 14.760 kg. The Levene test 
showed identical variances of the distributions 
analyzed (F = 0.810, p = 0.370), whereas t-test yielded 
no statistically significant differences in the mean 
weight gain between the preeclampsia women with 
control women with normal course of pregnancy             
(t = 0.813, p = 0.418) (Table 2). 
The mean BMI in the group of women with 
preeclampsia was 32.235 kg/m2; by median, BMI was 
≤ 31.590 kg/m2 in one half and ≥ 31.590 kg/m2 in the 
other half of these women. In the control group, the 
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mean BMI was 27.766 kg/m2. The Levene test showed 
different variances of the distributions analyzed (F = 
9.909, p = 0.002), whereas t-test yielded a statistically 
significant difference in the mean BMI between the 
preeclampsia group and control group of women with 
a normal course of pregnancy (t = 5.164, p = 0.000) 
(Table 3). 
 
Table 1 Pregestational weight - statistical data in preeclamptic and control groups 
Tablica 1. Pregestacijska debljina – statistički podaci u kontrolnim skupina i skupinama preklampsije 
 
 
Table 2 Gestational growth weight - statistical data in preeclamptic and control groups 




Gestational growth weight  / Porast gestacijske težine 





Number of cases / Broj slučajeva 55 50 
Arithmetic middle / Artimetička sredina 15.709 14.760 
Median / Prosjek  15.000 14.500 
Minimal values / Minimalne vrijednosti 5.000 4.000 
Maximal values / Maksimalne vrijednosti 32.000 30.000 
Over quartil / Iznad kvartila 10.000 10.000 
Under quartil / Ispod kvartila 19.000 18.000 
Interquartil / Međukvartil  9.000 8.000 
Standard deviation / Standardna devijacija 6.259 5.648 
 
Table 3 Body mass indexes in preeclamptic and control groups 










Number of cases / Broj slučajeva 55 50 
Arithmetic middle / Artimetička sredina 32.235 27.766 
Median / Prosjek 31.590 27.365 




Weight  / Težina  





Number of cases / Broj slučajeva 55 50 
Arithmetic middle / Artimetička sredina 88.195 77.030 
Median / Prosjek 86.000 77.000 
Minimal values / Minimalne vrijednosti 60.000 50.000 
Maximal values / Maksimalne vrijednosti 126.000 116.000 
Over quartil / Iznad kvartila 78.000 70.400 
Under quartil / Ispod kvartila 99.000 82.500 
Interquartil / Međukvartil  21.000 12.100 
Standard deviation / Standardna devijacija  16.171 11.556 





The rising trend of obesity worldwide is considered 
to be responsible for the increasing prevalence of 
preeclampsia, perinatal complications and infertility 
due to the higher risk of cardiovascular and metabolic 
disorders.5,7 The exact mechanism associating obesity 
or insulin resistance with preeclampsia has not yet 
been fully elucidated. It may possibly be explained         
by the increased stress along with hyperdynamic 
circulation, dyslipidemia, or enhanced cytokine 
mediated oxidative stress, enhanced sympathetic 
activity, increased renal sodium resorption, or direct 
interference of insulin resistance or hyperinsulinism 
with placentation.8,9 In their retrospective study, 
Barden et al. demonstrated that women with 
preeclampsia had higher BMI and blood pressure 
levels before pregnancy as compared with 
normotensive control subjects, suggesting their 
predisposition to a metabolic syndrome.10 In Croatia, 
the relationship of obesity, gestational weight gain and 
preeclampsia has not yet been studied at national level. 
Obesity as a risk factor for preeclampsia has also been 
reported by Sibai et al.1 In our study, analysis of the 
mean gestational weight gain yielded similar results, as 
there was no statistically significant between-group 
difference (mean gestational weight gain 15.709 ± 
6.259 kg in the preeclampsia group and 14.760 ± 5.648 
kg in the control group). Statistically significant 
between-group differences were found in the mean 
gestational BMI as well as in the mean pregestational 
BMI values, indicating that increased pregestational 
BMI posed a risk of developing preeclampsia in 
pregnancy, which is consistent with the literature 
reports mentioned above and below. In their 
retrospective cohort study, Bhattacharya et al. 
followed-up a cohort of nulliparae during a 30-year 
period. Study women were divided into five groups 
according to BMI values. The risk of preeclampsia was 
found to be highest (OR 7.2; 95% CI 4.7, 11.2) in the 
group of women with morbid obesity (BMI 30-34.9 
kg/m2) and lowest (OR 0.6; 95% CI 0.5, 0.7) in the 
group of underweight women (BMI < 20 kg/m2). The 
rate of pregnancy termination by cesarean section was 
highest in the group women with morbid obesity (OR 
2.8; 95% CI 2.0, 3.9). The risk of delivering a newborn 
of >4000 g birth weight was also highest in the group 
of women with morbid obesity (OR 0.5; 95% CI 0.4, 
0.6). The authors conclude that elevated BMI is 
associated with an increased incidence of preeclampsia, 
gestational hypertension, macrosomia, and pregnancy 
termination by cesarean section.11  
Pregnancy complicated by preeclampsia poses a 
risk of vascular disease (arterial hypertension, stroke, 
and myocardial infarction) and should definitely 
stimulate lifestyle modification and avoidance of risk 
factors. It is considered that conditions comparable to 
those found in adults with arterial hypertension, 
obesity or diabetes, primarily systemic inflammatory 
response, also characterize preeclampsia in young 
women12-15 In our study, we found that the women with 
preeclampsia had significantly higher BMI values at 
conception as compared to the group of pregnant 
women with a normal course of pregnancy, suggesting 
the increased pregestational BMI to be a risk factor for 




Therefore, appropriate health education of adipose 
pregnant women and those with risk factors, along 
with their identification, is of utmost public health 
importance to reduce the rate of excessive gestational 
weight gain, preeclampsia, and associated short-term 
and long-term comorbidity. However, it should be 
noted that randomized studies, yet many of them on 
small samples, found no beneficial effects of dietary 
(Mediterranean) measures or use of various 
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